Spending like a bigger company on purpose: current results carry the cost of an expansion aimed at demand management say
The model's full reasoning — Q3 2023 call → NOWe need to determine if management acknowledges that current results are weighed down by an expansion already undertaken, and justifies it with demand already real. Let's examine the transcript. Key points: Heimbach acquisition completed August 31, 2023. That's an expansion. It added revenue but also costs. Management says "Heimbach was slightly dilutive to GAAP EPS for the quarter, about $0.01 per share." Also "Heimbach reduced net income by approximately $500,000." And "we will incur $5.5 million of inventory step-up for the full year 2023 relating to the transaction." Also "Heimbach's estimated annual G&A, including the impact of purchase accounting will be approximately $12 million to $13 million going forward." So they acknowledge the acquisition is costing money now, diluting earnings. That's an expansion already undertaken. Now, do they justify it with demand already real? They talk about integration, cost savings, and expect it to become accretive in 2025. But do they point to existing demand? They mention "We have a clear line of sight into the cost savings and efficiency opportunities" but that's cost savings, not demand. They don't explicitly say that Heimbach brings in orders or customers that are already there. They say "Heimbach operations added nearly $16 million of revenue" so it has revenue. But the justification for the acquisition is not clearly tied to demand that is already showing up. They talk about long-term growth, but not specific orders or contracts. They mention "The Company is executing well" and "well positioned" but not specific demand. Also, the question asks about "expansion" - could be the Heimbach acquisition. But is it "capacity, footprint, or organization added ahead of the revenue it will serve"? Yes, they added a whole company. And they acknowledge it's dilutive now. But do they justify it with demand already real? They say "expect acquisition will become accretive to earnings and cash flow in 2025" - that's future. They don't say "we already have orders from Heimbach's customers" or "we see demand." They mention "The Machine Clothing business continues to perform very well" but that's not specifically about Heimbach. They also mention "We have a clear line of sight into the cost savings" - that's cost, not demand. So the justification is not about demand already real; it's about future accretion and cost savings.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| PUMP | ProPetro Holding Corp. | Q4 2023 | 2024-02-21 | C+ |
| PTLO | Portillo's Inc. | Q2 2023 | 2023-08-05 | B |
| AFL | Aflac Incorporated | Q2 2023 | 2023-08-02 | C+ |
| KE | Kimball Electronics, Inc. | Q3 2023 | 2023-05-06 | C+ |
| SIBN | SI-BONE, Inc. | Q3 2022 | 2022-11-07 | C+ |
| CHE | Chemed Corporation | Q3 2022 | 2022-11-01 | B+ |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| WD | Walker & Dunlop, Inc. | Q2 2022 | 2022-08-09 | C+ |
| OGI | OrganiGram Holdings Inc. | Q3 2022 | 2022-07-14 | B+ |
| FLYW | Flywire Corporation | Q1 2022 | 2022-05-14 | B+ |
| HLIO | Helios Technologies, Inc. | Q1 2022 | 2022-05-10 | C |
| IRTC | iRhythm Technologies, Inc. | Q1 2022 | 2022-05-07 | C+ |
| GTES | Gates Industrial Corporation plc | Q4 2021 | 2022-02-07 | C+ |
| LMAT | LeMaitre Vascular, Inc. | Q3 2021 | 2021-10-29 | C+ |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| JBT | John Bean Technologies Corporation | Q2 2018 | 2018-07-26 | B |
| CP | Canadian Pacific Railway Limited | Q2 2018 | 2018-07-19 | B+ |
| AOSL | Alpha and Omega Semiconductor Limited | Q2 2018 | 2018-02-07 | B |
| IR | Ingersoll-Rand Plc | Q3 2017 | 2017-10-25 | B |
| FLEX | Flex Ltd. | Q1 2018 | 2017-07-28 | F |
SIBN · Q3 2022 → YESThe question is: Does management acknowledge that the company's CURRENT reported results are being visibly weighed down by the cost of an expansion the company has ALREADY undertaken — spending, hirin...YES Management explicitly describes the expansion as already underway and costing the company now: investments in sales force (85 territory managers + 72 specialists), new products (iFuse-TORQ, iFuse-Bedrock Granite), instrument trays, inventory, and R&D that are driving higher depreciation, freight, and product costs 84% gross margin (down low-single digits from these factors). Anshul confirms “we’ve made a substantial amount of investment whether it’s in TORQ trays or Granite trays or TORQ implants” and “this is going to lead to elevated depreciation,” while Laura notes the build supports “strong new product demand.
FLYW · Q1 2022 → YESThe question is: Does management acknowledge that the company's CURRENT reported results are being visibly weighed down by the cost of an expansion the company has ALREADY undertaken, AND justify carr...YES The transcript shows management explicitly linking the current EBITDA decline to the hiring expansion already completed ("increased the number of FlyMates by over 50% during the past year" and "added over 100 new FlyMates within the sales, marketing and product functions"), while framing the spending as a deliberate, ongoing 2022 investment plan that is already delivering observable results through record client adds (130), pipeline growth, and strong ARR signings.
EVGO · Q2 2022 → YESThe question is: Does management acknowledge that the company's CURRENT reported results are being visibly weighed down by the cost of an expansion the company has ALREADY undertaken, AND justify carr...YES Management describes concrete expansion already underway—170 stalls placed in Q2, total stalls at 2,397 with 460 under construction, pipeline at 3,669, CapEx jumped to $44 million to accelerate deployment, and G&A ramping personnel to support growth—while directly tying the resulting negative adjusted EBITDA of -$19.8 million to that deliberate build-out.